183 related articles for article (PubMed ID: 18303440)
1. An unexpected abdominal 18F-fluorodeoxyglucose (FDG) uptake on positron emission tomography (PET) in a patient with limited stage small cell lung cancer.
Decoster L; Stroobants S; Verbeken E; Nackaerts K; Vansteenkiste J
J Thorac Oncol; 2008 Feb; 3(2):174-6. PubMed ID: 18303440
[TBL] [Abstract][Full Text] [Related]
2. Positron emission tomography in limited-stage small-cell lung cancer: a prospective study.
Bradley JD; Dehdashti F; Mintun MA; Govindan R; Trinkaus K; Siegel BA
J Clin Oncol; 2004 Aug; 22(16):3248-54. PubMed ID: 15310768
[TBL] [Abstract][Full Text] [Related]
3. Staging and monitoring of small cell lung cancer using [18F]fluoro-2-deoxy-D-glucose-positron emission tomography (FDG-PET).
Kut V; Spies W; Spies S; Gooding W; Argiris A
Am J Clin Oncol; 2007 Feb; 30(1):45-50. PubMed ID: 17278894
[TBL] [Abstract][Full Text] [Related]
4. 18F-fluorodeoxyglucose positron emission tomography in small-cell lung cancer.
Zhao DS; Valdivia AY; Li Y; Blaufox MD
Semin Nucl Med; 2002 Oct; 32(4):272-5. PubMed ID: 12524651
[TBL] [Abstract][Full Text] [Related]
5. Is there a role for positron emission tomography/computed tomography in the staging of small-cell lung cancer?
Truong MT; Marom EM
Clin Lung Cancer; 2008 Jan; 9(1):8. PubMed ID: 18282351
[No Abstract] [Full Text] [Related]
6. Whole-body 18F-2-deoxyglucose positron emission tomography in primary staging small cell lung cancer.
Shen YY; Shiau YC; Wang JJ; Ho ST; Kao CH
Anticancer Res; 2002; 22(2B):1257-64. PubMed ID: 12168935
[TBL] [Abstract][Full Text] [Related]
7. Comparison of FDG-PET findings of brain metastasis from non-small-cell lung cancer and small-cell lung cancer.
Lee HY; Chung JK; Jeong JM; Lee DS; Kim DG; Jung HW; Lee MC
Ann Nucl Med; 2008 May; 22(4):281-6. PubMed ID: 18535878
[TBL] [Abstract][Full Text] [Related]
8. Impact of 18F-fluorodeoxyglucose positron emission tomography in the staging and treatment response assessment of extra-pulmonary small-cell cancer.
Gregory DL; Brennan SM; Stillie A; Herschtal A; Hicks RJ; MacManus MP; Ball DL
J Med Imaging Radiat Oncol; 2010 Apr; 54(2):100-7. PubMed ID: 20518871
[TBL] [Abstract][Full Text] [Related]
9. Detection of unsuspected distant metastases and/or regional nodes by FDG-PET [corrected] scan in apparent limited-disease small-cell lung cancer.
Niho S; Fujii H; Murakami K; Nagase S; Yoh K; Goto K; Ohmatsu H; Kubota K; Sekiguchi R; Nawano S; Saijo N; Nishiwaki Y
Lung Cancer; 2007 Sep; 57(3):328-33. PubMed ID: 17537538
[TBL] [Abstract][Full Text] [Related]
10. Is combined 18F-fluorodeoxyglucose-positron emission tomography/computed tomography superior to positron emission tomography or computed tomography alone for diagnosis, staging and restaging of pancreatic lesions?
Casneuf V; Delrue L; Kelles A; Van Damme N; Van Huysse J; Berrevoet F; De Vos M; Duyck P; Peeters M
Acta Gastroenterol Belg; 2007; 70(4):331-8. PubMed ID: 18330088
[TBL] [Abstract][Full Text] [Related]
11. Whole-body (18)F-FDG PET improves the management of patients with small cell lung cancer.
Kamel EM; Zwahlen D; Wyss MT; Stumpe KD; von Schulthess GK; Steinert HC
J Nucl Med; 2003 Dec; 44(12):1911-7. PubMed ID: 14660716
[TBL] [Abstract][Full Text] [Related]
12. [Value of fluorine-18 fluorode oxyglucose-positron emission tomography in patients with small cell lung cancer].
Yu CH; Wang T; Yin DY; Sun YE; Tian JH; Yao SL
Zhonghua Yi Xue Za Zhi; 2004 Feb; 84(3):229-32. PubMed ID: 15059541
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of [18F]FDG-PET imaging in small cell lung cancer.
Pandit N; Gonen M; Krug L; Larson SM
Eur J Nucl Med Mol Imaging; 2003 Jan; 30(1):78-84. PubMed ID: 12483413
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of positron emission tomography/computed tomography findings in limited-stage small cell lung cancer before chemoradiation therapy.
Gomez DR; Gladish GW; Wei X; Kotamarti KR; Allen PK; Cox JD; O'Reilly MS; Erasmus JJ; Fossella FV; Komaki R
Am J Clin Oncol; 2014 Feb; 37(1):77-80. PubMed ID: 23111360
[TBL] [Abstract][Full Text] [Related]
15. Lung cancer.
Akhurst T; MacManus M; Hicks RJ
PET Clin; 2015 Apr; 10(2):147-58. PubMed ID: 25829084
[TBL] [Abstract][Full Text] [Related]
16. Impact of positron emission tomography on the management of patients with small-cell lung cancer: preliminary experience.
Blum R; MacManus MP; Rischin D; Michael M; Ball D; Hicks RJ
Am J Clin Oncol; 2004 Apr; 27(2):164-71. PubMed ID: 15057156
[TBL] [Abstract][Full Text] [Related]
17. Critical review of PET-CT for radiotherapy planning in lung cancer.
Senan S; De Ruysscher D
Crit Rev Oncol Hematol; 2005 Dec; 56(3):345-51. PubMed ID: 15990331
[TBL] [Abstract][Full Text] [Related]
18. Histologic results of para-aortic lymphadenectomy in patients treated for stage IB2/II cervical cancer with negative [18F]fluorodeoxyglucose positron emission tomography scans in the para-aortic area.
Boughanim M; Leboulleux S; Rey A; Pham CT; Zafrani Y; Duvillard P; Lumbroso J; Haie-Meder C; Schlumberger M; Morice P
J Clin Oncol; 2008 May; 26(15):2558-61. PubMed ID: 18487573
[TBL] [Abstract][Full Text] [Related]
19. Impact of computed tomography and 18F-deoxyglucose coincidence detection emission tomography image fusion for optimization of conformal radiotherapy in non-small-cell lung cancer.
Deniaud-Alexandre E; Touboul E; Lerouge D; Grahek D; Foulquier JN; Petegnief Y; Grès B; El Balaa H; Keraudy K; Kerrou K; Montravers F; Milleron B; Lebeau B; Talbot JN
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1432-41. PubMed ID: 16125870
[TBL] [Abstract][Full Text] [Related]
20. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]